D. Snijders (Berkhout, Netherlands), M. Vendrell Relat (Girona, Spain), A. Liapikou (Athens, Greece), A. Koutsoukou (Athens, Greece)
Individual monitoring of procalcitonin and C-reactive protein levels as a criterion for cancel of antibiotic therapy in patients with severe community-acquired pneumonia
K. Bielosludtseva, T. Pertseva, T. Kyreeva (Dnipropetrovsk, Ukraine)
|   |
Usefulness of multiplex real-time polymerase chain reaction for diagnosing community acquired pneumonia in Japanese adults
Y. Yoshii, K. Shimizu, M. Morozumi, N. Chiba, K. Ubukata, M. Kawaishi, K. Saito, J. Araya, K. Nakyama, K. Kuwano (Tokyo, Japan)
| |
Effects of vaccination on clinical presentation of community acquired pneumonia (CAP)
E. Demirdogen çetinoglu, E. Uzaslan, A. çilli, O. Kilinç, A. Sakar Coskun, A. Sayiner, A. Hazar, N. Kokturk, A. Filiz, M. Polatli (Bursa, Antalya, Izmir, Manisa, Istanbul, Ankara, Gaziantep, Aydin, Turkey)
| |
Importance of early bronchoalveolar lavage in immunocompromised patients
S. Cedeño de Jesús, C. Merinas López, N. Burgos Guadix (Granada, Spain)
| |
Patterns of spirometry in bronchiectasis patients and relationship to markers of disease severity and hospitalisation
R. Stretton, L. Poppelwell, W. Salih, J. Chalmers, T. Fardon (Dundee, United Kingdom)
| |
Relation between bacteremia and septic shock in patients with pneumococcal community-acquired pneumonia
A. Uranga, A. Capelastegui, P. P. Espana, R. Díez, R. Zalacaín, L. A. López, A. Bilbao, A. P. Martínez (Galdakao, Bilbao, Spain)
| |
Factors related with prolongued length of stay in good prognosis community acquired pneumonia
P. J. Marcos, I. Vidal, F. J. González-Barcala, P. Sanjuán, H. Verea, P. Marcos-Velázquez (A Coruña, Ferrol, Santiago de Compostela, Lugo, Ourense, Spain)
| |
Study of pleural empyema evolution depending on drainage size used
S. Herrero, A. A. Iridoy, V. López, M. I. Andrade, P. Cebollero, I. Pascal (Pamplona, Spain)
| |
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
K. Bielosludtseva, T. Kireeva (Dnipropetrovsk, Ukraine)
| |
Inflammatory markers and community acquired pneumonia (CAP): Prognosis analisis and predictive capacity in the short term
A. Pando, B. Prieto, M. Ariza, M. Clemente, C. Madrid, S. Gagatek, H. Buchelli, L. Molinos, P. Casan (Oviedo, Spain)
| |
Community acquired pneumonia in patients with ambulatory treatment. Etiology and evolution
M. Ariza, L. Molinos, J. Cason, A. Enriquez, A. Pando, D. Fole, H. Buchelli, P. Casan (Oviedo, Spain)
| |
Role of procalcitonin (PCT) as a marker of severity of community acquired bacterial pneumonia (CABP) compared to PSI, CRB65 abd CURB65
L. Fernandes, A. Mesquita, A. Arora (P.O. Caranzalem, India)
| |
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
E. Lozo Vukovac, K. Mise, I. Gudelj, I. Peric (Split, Croatia)
| |
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
J. Ben Halima, W. Ben Ahmed, L. El Gharbi, B. Dhari, S. Azzabi, M. A. Baccar, H. Aouina, H. Bouacha (Tunis, Tunisia)
| |
Blood urea nitrogen/ albumin ratio: Is it a new predictor for prognosis of community-acquired pneumonia?
E. Akpinar, D. Hosgün, B. Doganay, M. Gulhan (Ankara, Turkey)
| |
Cellular and physiological characterisation of a murine model of long-term pulmonary infection with streptococcus pneumoniae
L. Haste, K. Hulland, K. McKechnie, P. Andrew (Leicester, Loughborough, United Kingdom)
| |
Urinary antigen of S. pneumoniae in the microbiological diagnosis of lower respiratory tract infections
S. Cedeño de Jesús, J. Gutierrez Fernandez, A. Sorlózano (Granada, Spain)
| |
Accuracy of diagnosis of pneumonia in an UK hospital participating in the advancing quality initiative
D. Tarpey, A. Youzgin (Southport, United Kingdom)
| |
Prevalence of hiatus hernia in non-cystic fibrosis bronchiectasis and associations with disease severity
M. McDonnell, M. Ahmed, D. Wall, J. Bruzzi, M. O'Mahoney, D. Breen, A. O'Regan, J. J. Gilmartin, R. Rutherford (Galway, Ireland)
| |
Etiological features of low respiratory tract infections in the department of pulmonology
R. Bontsevich, G. Tafintseva, V. Kulikovsky, M. Pokrovsky, T. Pokrovskaia, Y. Afanasjev (Belgorod, Russian Federation)
| |